DAFTAR PUSTAKA
American Lung Association State of Lung Disease in Diverse Communities. 2010. Chronic Obstructif Pulmonary Disease COPD: 35-39.
Arja, C., Ravuri. R.R., Pulamaghatta. V.N., Surapaneni., K.M., Raya, P., Adimoolam, C., dan Kanala, K.R. 2014. Genetic Determinants of Chronic Obstructive Pulmonary Disease in South Indian Male Smokers. Plos One, Volume 9, Nomor 2: e89957.
Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan Republik Indonesia (RI). 2013. Laporan Riset Kesehatan Dasar (RISKESDAS). Updated Desember 2014.
Cai, J., Wang, L., dan Wang, A. 2010. MMP-1 Gene Polymorphism and COPD Susceptibility in Han Nationality in Jiangxi Province. Shandong Medical Journal, Volume 50: 77.
Cheng, S.L., Yu, C.J., dan Yang, P.C. 2009. Genetic Polymorphism of Cytochrome p450 and Matrix Metalloproteinase in Chronic Obstructive Pulmonary Disease. Biochem Genet, Volume 47: 600.
Churg, A., Zhou, S., dan Wright, J.L. 2012. Matrix Metalloproteinases in COPD. Eur Respir J, Volume 39: 197-209.
CAT Development Steering Group. COPD Assessment Test (CAT) User Guide. 2009. Last updated: February 24, 2012. Available from :http://www.catestonline.org/images/UserGuides/CATHCPUser%20guideEn.pdf
Depkes RI. 2007. Survei Sosial Ekonomi Nasional (SUSENAS). Profil Kesehatan Indonesia.
Enewold, L., Mechanic, L.E., Bowman, E.D., Platz, E.A., dan Alberg, A.J. 2012. Association of Matrix Metalloproteinase-1 Polymorphism with Risk of COPD and Lung Cancer and Survival in Lung Cancer.Anticancer Res, Volume 32: 3920.
Han, W., Kuang, J., dan Rao, W. 2010. MMP-9 Polymorphisms and Susceptibility to Chronic Obstructive Pulmonary Disease. Chin J Tuberc Respir Dis, Volume 29: 278.
Haq, I., Chappel, S., Johnson, S.R., Lotya, J., Daly, L., Morgan, K., Guetta-Baranes, T., Roca, J., Rabinovich, R., Millar, A.B., Donnelly, S.C., Keatings, V., MacNee, W., Stolk, J.,Hiemstra, P.S., Miniati, M., Monti, S., O’Connor, C.M., dan Kalsheker, N. 2010. Association of MMP-12 Polymorphisms with Severe and Very Severe COPD: A Case Control Study of MMPs-1, 9 and 12 in a European Population. BMC Medical Genetics, Volume 11, Nomor 7: 1-11.
Hersh, C.P., DeMeo, D.L., Lazarus, R., Celedon, J.C., Raby, B.A., Benditt, J.O., Criner, G., Make, B., Martinez F.J dan Scanlon, P.D.2006. Genetic Association Analysis of Functional Impairment in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med, Volume 173, Nomor 9: 982.
http://www.had2know.com/academics/hardy-weinberg-equilibrium-calculator-2-alleles.html. Last updated Desember, 2014.
Hudoyo, A, Sp.P. Edisi Revisi 2011. Penatalaksanaan Asma dan PPOK Pada Orang Dewasa Berdasar Pedoman GINA (Global Initiative for Asthma) & GOLD (Global initiative for Chronic Obstructive Lung Disease): 1-9.
Svartengren, M., Pershagen, G., Wickman, M., Lange, C., Demeo, D.L., Hersh, C.P, Klanderman, B.J., Raby, B.A., Sparrow, D., Shapiro, S.D., Silverman, E.K., Litonjua, A.A., Weiss, S.T., dan Celedon, J.C. 2009. MMP12, Lung Function, and COPD in High-Risk Population. The New England Journal of Medicine: 2, 8.
Ishii, T., Matsuse, T., Teramoto, S., Matsui, H., Miyao, M., Hosoi, T., Takahashi, H., Fukuchi, Y., dan Ouchi, Y. 2006. Glutathione S-transferase P1 (GSTP1) Polymorphism in Patients with Chronic Obstructive Pulmonary Disease. Thorax, Volume 54: 693-696.
Ito, I. et al. 2008. Matrix Metalloproteinase-9 Promoter Polymorphism Associated With Upper Lung Dominant Emphysema. Am J Respir Crit Care Med, Volume 172: 1382.
Joshi, J.M. 2008. Chronic Obstructive Pulmonary Disease: Knowing What We Mean, Meaning What We Say, Review Article. The Indian Journal of Chest Diseases & Allied Sciences, Volume 50: 89-95.
Jurnal Respirologi Indonesia. 2007. Penyakit Paru Obstruktif Kronik Sebagai Penyakit Sistemik: 1-5.
Keputusan Kementerian Kesehatan Republik Indonesia no.1022/Menkes/SK/XI/2011. Pedoman Pengendalian Penyakit Paru Obstruktif Kronik: 10.
Korytina, G.F., Akhmadishina, L.Z., Ianbaeva, D.G., dan Victorova, T.V. 2008. Polymorphism in Promoter Regions of Matrix Metalloproteinases (MMP1, MMP9, and MMP12) in Chronic Obstructive Pulmonary Disease Patients. Russian Journal of Genetics, Volume 44: 206.
Lee, S.Y. et al. 2010. Polymorphism in Matrix Metalloproteinase-1, -9, and -12 Genes and The Risk of Chronic Obstructive Pulmonary Disease in a Korean Population. Respiration, Volume 80: 137.
Li, W., Jin, X., Zhou, Y., Zhu, M., Lin, X.F., Hu, X., Wang,W., Wang, F., dan Jin, G. 2012. Lack of Independent Relationship between The MMP-12 Gene Polymorphism and Carotid Plaque Susceptibility in The Chinese Han Population.Vascular Medicine, Volume 17, Nomor 5: 310–316.
Nakamura, H. 2011. Genetics of COPD. Allergology International, Volume 60 : 253-254.
Nguyen, S.V., Skarstedt, M., Lofgren, S., Zar, N., Andersson, R.E., Lindh, M., Matussek, A., dan Dimberg, J. 2013. Gene Polymorphism of Matrix
Metalloproteinase-12 and -13 and Association with Colorectal Cancer in
Oemiati, R. 2013. Kajian Epidemiologis Penyakit Paru Obstruktif Kronik (PPOK). Media litbangkes, Volume 23, Nomor 2: 82-88.
Perhimpunan Dokter Paru Indonesia. 2008. Penyakit Paru Obstruktif Kronik (PPOK) Pedoman Diagnosis & Penatalaksanaan di Indonesia: 2-6.
Santus, P. et al. 2009. Stromelysin 1 Polymorphism as a New Potential Risk Factor in Progression of Chronic Obstructive Pulmonary Disease. Monaldi Arch Chest Dis, Volume 71: 16.
Sastroasmoro, S dan Ismael, S. 2011. Dasar-dasar Metodologi Penelitian Klinis. Jakarta, Penerbit Sagung Seto: 146-166.
Schirmer, H., da Silva, L.B., Teixeira, P.J.Z., Moreira, J.S., Moreira A.L.S., dan Simon, D. 2009. Matrix Metalloproteinase Gene Polymorphisms: Lack of Association With Chronic Pulmonary Disease in a Brazilian Population. Genetic and Molecular Research: Volume 8: 1030-1031.
Song, Y., Xie, Y., Liu, F., Zhao, C., Yu, R., Ban, S., Ye, Q., Wen, J., Wan, H., Li, X., Ma, R., dan Meng, Z. 2013. Expression of Matrix Metalloproteinase-12 in Aortic Dissection. BioMed Central Cardiovascular Disorders: Volume 13: 3-9.
Sun, C., Wang, W., Yang, J., Siqingaowa, dan Wang, L. 2012. The Association of Matrix metalloproteinase 3, 12 Polymorphism with Susceptibility of Chronic Obstructive Pulmonary Disease. Chin J Clinicians (Electronic Edition), Volume 6: 5829.
Supriyadi, M. 2013. Faktor Genetik Penyakit Paru Obstruktif Kronik. CDK-207, Volume 40, Nomor 8: 572-578.
Tacheva, T., Dimov., D., Aleksandrova, E., Gulubova, M., dan Vlaykova, T. 2014. Common Promoter Polymorphism MMP-12 -82A/G in a Population from Central Bulgaria. Science and Technologies Medicine, Volume 4: 140-143.
Tarigan, A.P. 2012. Hubungan Polimorfisme Gen TNFα Pada Posisi -308 dan -238 Dengan Kejadian Penyakit Paru Obstruktif Kronik. Disertasi, Program Studi Doktor Ilmu Kedokteran, Universitas Sumatera Utara, Medan.
Teramoto, S. 2007. COPD Pathogenesis from the View Point of Risk Factors. The Japanese Society of Internal Medicine: 77-78.
are a Risk Factor for COPD. Int J Chron Obstruct Pulmon Dis, Volume 1, Nomor 3: 268.
Van Diemen, C.C. et al. 2011. Genetic Variation in TIMP1 but not MMPs Predict Excess FEV1 Decline in Two General Population-Based Cohorts. Respir Res, Volume 12: 57.
Vlaykova, T., dan Dimov, D. 2011. Polymorphisms of Matrix Metalloproteinases (MMP) in COPD. Biotechnology & Biotechnological Equipment, Volume 26: 116.
Wieczorek, E., Reszka, E., Jablonowski, Z., Jablonska, E., Krol, M.B., Grzegorczyk, A., Gromadzinska, J., Sosnowski, M., dan Wasowicz, W. 2013. Genetic Polymorphisms in Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of MPs (TIMPs), and Bladder Cancer Susceptibility. BJU International, Volume 112: 1211-1212.
Wood, A.M., Tan, S.L., dan Stockley, R.A. 2009. Review: Chronic Obstructive Pulmonary Disease: Towards Pharmacogenetics. Genome medicine, Volume 1, Nomor 112: 1-2,6.
